NEW: FDA allows pharmacists to prescribe Paxlovid COVID treatment
The Food and Drug Administration said Wednesday it's allowing state-authorized pharmacists to prescribe Pfizer's antiviral treatment Paxlovid.for the FDA to allow them to prescribe the medication, saying that it would ultimately expand access to the antivirals.
Paxlovid is authorized for the treatment of "mild-to-moderate" COVID-19 in adults and pediatric patients that have tested positive and are considered to be at high risk of developing severe disease.The FDA revised its Emergency Use Authorization for Paxlovid to allow pharmacists to prescribe the medication under specific limitations. Patients must test positive for the virus and show health records for a pharmacist to review for kidney or liver problems.
Patients must also show pharmacists a list of all the medications they are taking in case they have "potentially serious interactions with Paxlovid.""The FDA recognizes the important role pharmacists have played and continue to play in combatting this pandemic,” said Patrizia Cavazzoni, director for the FDA’s Center for Drug Evaluation and Research.
“Since Paxlovid must be taken within five days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access to timely treatment for some patients who are eligible to receive this drug for the treatment of COVID-19.”
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA temporarily suspends order banning Juul cigarettesThe Food and Drug Administration has issued a stay of its recent order for vaping company Juul to pull its electronic cigarettes from the market. The FDA says the stay is temporary while it conducts further review.
Read more »
'Unique' Issues Cause FDA To Temporarily Suspend Ban On Juul CigarettesThe FDA issued the initial order banning Juul sales on June 23. A day later, a federal appeals court temporarily blocked the government ban.
Read more »
FDA temporarily suspends order banning Juul cigarettesThe Food and Drug Administration said on Twitter that the stay temporarily suspends the marketing denial order while it conducts further review, but does not rescind it.
Read more »
FDA decision on Eisai, Biogen Alzheimer's drug due in JanuaryThe U.S. Food and Drug Administration will expedite its review of Eisai Co Ltd's and Biogen Inc's experimental Alzheimer's drug lecanemab, with a decision due by Jan 6, 2023, the companies said on Tuesday.
Read more »
Juul Can Keep Selling Its Products in U.S. While It Appeals Ban, FDA SaysThe FDA says it will allow Juul to stay on the U.S. market while the e-cigarette maker appeals the agency’s ban
Read more »
Serious Illnesses From Daily Harvest Lentil Crumbles, FDA Investigates - MedicineNet Health NewsFallout is mounting for the food delivery service Daily Harvest, which has voluntarily recalled a frozen food product suspected of sickening hundreds of customers in at least 26 states.
Read more »